Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Total-Long-Term-Assets" stands at 2.08 Trillion Japanese Yens as of 09/30/2025.
As of the end of Astellas Pharma Inc.'s second quarter, the item "Total Long Term Assets" stands at 2.08 Trillion JPY. This represents an increase of 1.91 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -7.87 percent compared to the value the year prior.
The 1 year change in percent is -7.87.
The 3 year change in percent is 36.53.
The 5 year change in percent is 46.88.
The 10 year change in percent is 154.74.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Assets | 280,205,508,085.11 |